Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers by CNBC Markets | October 1, 2025 7:18 pm | US Markets Pfizer’s deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar deals that would make them immune to tariffs.
